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Brief CommunicationHSP70 induces liver X receptor pathway
activation and cholesterol reduction in vitro and
in vivoBurcin Gungor 1,2,6,7, Lauri Vanharanta 1,2,7, Maarit Hölttä-Vuori 1,2, Juho Pirhonen 1,2, Nikolaj H.T. Petersen 3,
Silvia Gramolelli 4, Päivi M. Ojala 4,5, Thomas Kirkegaard 3, Elina Ikonen 1,2,*ABSTRACT
Objective: Heat Shock Proteins (HSPs) maintain cellular homeostasis under stress. HSP70 represents a major stress-inducible family member
and has been identiﬁed as a druggable target in inherited cholesterol-sphingolipid storage diseases. We investigated if HSP70 modulates
cholesterol accumulation in more common conditions related to atherogenesis.
Methods: We studied the effects of recombinant HSP70 in cholesterol-laden primary macrophages from human blood donors and pharma-
cological HSP70 upregulation in high-cholesterol diet fed zebraﬁsh.
Results: Recombinant HSP70 facilitated cholesterol removal from primary human macrophage foam cells. RNA sequencing revealed that HSP70
induced a robust transcriptional re-programming, including upregulation of key targets of liver X receptors (LXR), master regulators of whole-body
cholesterol removal. Mechanistically, HSP70 interacted with the macrophage LXRalpha promoter, increased LXRalpha and its target mRNAs, and
led to elevated levels of key proteins facilitating cholesterol efﬂux, including ATP-binding cassette transporters A1 and G1. Pharmacological
augmentation of endogenous HSP70 in high-cholesterol diet fed zebraﬁsh activated LXR and its target mRNAs and reduced cholesterol storage at
the whole organism level.
Conclusion: These data demonstrate that HSP70 exerts a cholesterol lowering effect in primary human cells and animals and uncover a nuclear
action of HSP70 in mediating cross-talk between HSP and LXR transcriptional regulation.
 2019 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Heat shock proteins (HSPs) are chaperones that facilitate protein
folding and transport, with essential roles in maintaining cell homeo-
stasis and survival [1]. The HSP70 family is evolutionarily the most
conserved subfamily, and the major stress-inducible member of this
family is HSP70-1 (HSPA1A, hereafter referred to as HSP70). A fraction
of HSP70 is released from stressed cells by an unconventional
mechanism, possibly involving exosomes and/or secretory lysosomes
[2]. In addition to its chaperone function in proteostasis, HSP70 can act
as a signaling molecule affecting cytokine production and functional
properties of immunocompetent cells via Toll-like receptors [3].
The therapeutic potential of HSP modulation is currently investigated in
several diseases, such as cancers and neurogenerative disorders [4,5],
but the role of HSPs in cholesterol metabolic regulation is not well
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HSPs have been implicated in the process, mostly owing to their
immunoinﬂammatory effects [6]. Some HSPs, such as HSP90, appear
to be pro-atherogenic and HSP90 inhibition exerts anti-atherogenic
effects in apolipoprotein E-deﬁcient mice [7,8]. In humans, high
circulating HSP70 levels are inversely related to the risk of coronary
artery disease [9e11] but whether HSP70 has bona ﬁde atheromo-
dulatory function(s) is not well understood.
In relation to lipids, HSP70 was shown to bind to the endo/lysosomal
phospholipid bis(monoacylglycero)phosphate (BMP), which functions
as a cofactor of lysosomal sphingolipid catabolism [12]. Treatment
with recombinant HSP70 (rHSP70) reduced lysosomal storage in
several sphingolipid storage diseases, suggesting that it provides a
potential candidate for their treatment [13]. Interestingly, reduction of
sphingolipid storage was accompanied by reduced cholesterol accu-
mulation in Niemann-Pick type C1 (NPC1) patient cells. The NPC1u 8 00290 Helsinki, Finland 2Minerva Foundation Institute for Medical Research,
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Brief Communicationprotein is crucial for exporting cholesterol from the endo/lysosomal
system [14] and HSP70 was shown to be important for its folding [15].
These ﬁndings raise the question if HSP70 has cholesterol lowering
potential in more common pathologies related to cholesterol
accumulation.
Here, we studied the effects of rHSP70 on human primary monocyte-
derived macrophage foam cells that accumulate cholesterol from
modiﬁed low-density lipoproteins (LDL). Such lesional macrophages
play important functions in all aspects of atherosclerosis [16]. We also
investigated the functional effects of HSP70-elevating pharmacological
compounds in high-cholesterol diet fed zebraﬁsh in vivo.
2. MATERIALS AND METHODS
2.1. Cells
Human buffy coat samples were obtained from the Finnish Red Cross
(Finnish Red Cross permit numbers 21/2015, 39/2016, 54/2017), in
accordance with the Declaration of Helsinki. Peripheral blood mono-
nuclear cells (PBMCs) were isolated by Ficoll layering [17] with Ficolle
Paque Premium (GE Healthcare), and differentiated to macrophages
during 7 days in vitro cultivation in serum-free macrophage media
(Gibco) in the presence of 10 ng/ml of GM-CSF (Invitrogen). Key re-
sources used in the study are summarized in Table S1.
2.2. Recombinant HSP70
Recombinant wild-type HSP70 and the BMP binding deﬁcient mutant
W90F-HSP70 were supplied by Orphazyme A/S. A standard ﬁnal
concentration of 300 nM rHSP70 was employed [12], as a 10-fold
higher concentration did not further increase the cholesterol
reducing effect and a 1: 10 concentration appeared less potent (Figure
S1AeD). Endotoxin levels of rHSP70 were determined as 2 EU/mg (by
FujiFilm, Billingham, UK), i.e. below the accepted maximum value of 5
EU/mg.
2.3. Cholesterol loading and efﬂux
PBMC derived macrophages were loaded with 50 mg/ml of acLDL for 3
days in macrophage serum-free medium (Macrophage-SFM), 100 U/
ml penicillin, 100 mg/ml streptomycin as described [18], to generate
foam cells mimicking early atherosclerotic cholesterol laden macro-
phages. During the last 16 h of acLDL loading, cells were incubated in
the presence of rHSP70 or vehicle control. Cholesterol efﬂux was
performed in complete medium (RPMI containing 10% FBS) for 12 h in
the presence or absence of wt or W90F mutant rHSP70. After efﬂux,
cells were washed and collected in PBS. Cells were lysed in RIPA
buffer containing protease inhibitors, 2% NaCl, or RNA lysis buffer for
protein, lipid and transcript analyses, respectively. For analyzing
radiolabeled cholesterol efﬂux, acLDL (50 mg/ml) was incubated with
[3H]cholesterol (1 mCi/ml) in macrophage-SFM for 3 h at room tem-
perature, and then added to macrophages for 3 days. During the last
16 h of loading, rHSP70 was applied to the samples indicated. [3H]-
cholesterol efﬂux to 10% FBS or 6% HDL-enriched serum (prepared by
polyethylene glycol precipitation as in [19]) in RPMI was measured for
3 h, as described [19], with rHSP70 present in the samples indicated.
2.4. Zebraﬁsh husbandry, embryo culture and diets
Zebraﬁsh (Danio rerio) larvae of the Turku strain have been maintained
in the laboratory forw20 years. The animal project permit (ESAVI/422/
04.10.07/2017) was obtained from the Animal Experiment Board of the
Regional State Administrative Agency of Southern Finland. Wild-type
zebraﬁsh larvae used in each experiment came from the same
breeding batch of ﬁsh and had a mixed parentage. Larvae were kept in136 MOLECULAR METABOLISM 28 (2019) 135e143  2019 The Authors. Published by Elsevier GmbH. Tstandard larval medium (5.00 mM NaCl, 0.44 mM CaCl2, 0.33 mM
MgSO4 and 0.17 mM KCl; referred to as E3) and raised at 28.5 C on a
14:10-h lightedark (LD) cycle until harvesting at the indicated time
points between 1 and 15 days post fertilization (dpf). Larvae were
raised in E3 on a Petri dish. From 5th dpf onwards, larvae were fed
either normal diet (ND) (SDS-100, Special Diet Services) or high
cholesterol diet (HCD; SDS-100 supplemented with 4% w/w choles-
terol, from Sigma Aldrich). Diets were replaced daily for 10 days. The
ﬁsh were starved for 24 h prior to harvesting. The larvae were
terminated mechanically after immersion in ice-cold water.
2.5. HSP70 inducers and their application
17-DMAG was from Invivogen and BGP-15 was from Sigma. 17-DMAG
was added to human macrophage foam cells at 500 nM concentration
during the last 16 h of acLDL loading and during the 12 h of efﬂux to
complete medium (RPMI containing 10% FBS, analogously to rHSP70
treatment). The inducers were administered together with HCD to the
larvae starting from 5th dpf on, at the indicated concentrations. 17-
DMAG was dissolved in DMSO and further diluted in E3 before
application to the ﬁsh. BGP-15 and BM were dissolved in PBS and kept
as stock at 20 C. 17-DMAG was applied every other day, BGP-15
and BM were applied daily; hsp70 mRNA levels were measured af-
ter 2 days of drug treatment on normal diet, and the other mRNAs on
HCD-fed ﬁsh at 15th dpf.
2.6. Western blotting
Protein lysates were cleared by centrifugation at 12000 rpm for
10 min at 4 C. Protein concentrations were determined using the Bio-
Rad protein assay kit, and equal amounts of total protein were loaded
on SDS-polyacrylamide gels. Western blots were performed using
monoclonal anti-HSP70 (1:3000), polyclonal anti-ABCA1 (1:500),
polyclonal anti-NPC1 (1:1000), polyclonal anti-FABP4 (1:2000) and
polyclonal anti-GRAMD1A (1:1000). The blots were developed using
the Clarity western enhanced chemiluminiscense substrate (Bio Rad).
Protein bands were normalized to stained membrane using Proact
membrane stain (Amresco). Quantitation of protein bands was per-
formed using ImageJ program (https://imagej.nih.gov/ij/).
2.7. Lipid analysis
Cells were harvested in 2% NaCl. Larvae were pooled in micro-
centrifuge tubes (5 larvae/condition) and excess water was removed.
Larvae were homogenized in 2% NaCl with a pestle, followed by
sonication and vigorous vortexing. Lipids were extracted as described
[20]. Lipids corresponding to equal amount of protein per sample were
separated by thin layer chromatography (TLC) using hexane:diethyl
ether:acetic acid, 80:20:1 as running solvent. The TLC plate was
charred (exemplary TLC in Figure S1C) and free cholesterol and cho-
lesteryl ester bands quantitated using ImageJ. For analyzing [3H]-
cholesterol efﬂux, radioactivity in medium and in cells was analyzed
by liquid scintillation counting after the 3 h efﬂux and percent
efﬂux was calculated as (radioactivity in medium/radioactivity in
cells þ medium) 100%, taking the average of three technical
replicates.
2.8. RNA isolation and qRT-PCR
Total RNAs were isolated using NucleoSpin RNA isolation kit
(MachereyeNagel, Cat. 740955-250). Cells were directly lysed using
RNA lysis buffer supplied in the kit. For larvae, 7 per condition were
pooled and homogenized in RNA lysis buffer by pestle strokes. 1.0 mg
of total RNA was transcribed using SuperScript VILO cDNA synthesis kit
(Invitrogen). Quantitative reverse transcription PCR (qRT-PCR) washis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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performed using Light Cycler 480 SYBER Green I Master Mix (Roche)
and a Light Cycler 480 II (Roche). Reaction steps; 95 C 150 and 40
cycles of 95 C 15 s, 60 C 30 s and 72 C 10 s, for human samples
and 95 C 15’ and 40 cycles of 95 C 5 s, 60 C 10 s and 72 C 13 s,
for ﬁsh samples. DD Ct method was used to calculate the results.
Relative quantities of human mRNAs were normalized to 18S and ﬁsh
mRNAs to b-actin. The oligonucleotides used for qRT-PCR are provided
in Table S2.
2.9. RNA sequencing
RNA samples of macrophage foam cells from 4 individual blood donors,
with cholesterol efﬂux performed in the presence or absence of rHSP70,
were used for sequencing. Samples were sequenced with Illumina
NextSeq sequencer (Illumina, USA) in one run using Ribo-Zero rRNA
removal and NEBNext Ultra Directional RNA Library prep. The
sequencing was performed as single end sequencing for read length 75
bp (SE75 or 1  75). RNA sequencing results were analyzed using
“Gene Set Enrichment Analysis”. 3D principal component analysis (PCA)
was performed to observe potential differential expression between
control and treated groups. 3D PCA plot demonstrated less scattered
control sample distribution and sample cohorts separated clearly in
the space deﬁned by the 3 ﬁrst principal components (Figure S2A).
Differential expression statistics revealed normalized raw data counts
of each sample and the signiﬁcance of changes in the presence of
rHSP0 treatment by adjusted p-values (p adj values) using DeSEQ2
program. Heatmaps were generated with the R heatmap2 function.
2.10. Chromatin immunoprecipitation (ChIP)
Efﬂux samples with or without rHSP70 treatment were crosslinked with
1% formaldehyde, incubated in 0.125M glycine and lysed in RIPA buffer
supplemented with protease (Pierce) and phosphatase (Pierce) in-
hibitors. Genomic DNA was fragmented in 400e600 bp fragments by
sonication using Misonix 3000, lysates were precleared by centrifu-
gation and incubated rotating overnight at 4 C with 5 mg of anti-HSP70
or 3 mg anti-HA-tag (HA:11, Biolegend) mouse monoclonal antibodies.
Protein G-coated magnetic beads (30 ml, Invitrogen) were added to the
samples and incubated rotating for 2e4 h at 4 C, washed once with
RIPA buffer, once with RIPA 0.5 M NaCl and once with RIPA 0.25 M LiCl
buffer. Washed beads were treated with 10 mg RNAse A for 1 h at 37 C
and with 20 mg Proteinase K at 65 C overnight. After DNA puriﬁcation
(MachereyeNagel PCR-puriﬁcation Kit), the LXRalpha promoter was
ampliﬁed by qRT-PCR (using primers provided in Table S2). Data were
analyzed according to the fold enrichment method, and for each indi-
vidual, the signals from the HSP70 samples were normalized to the
corresponding ones from HA samples.
2.11. Electrophoretic mobility shift assay (EMSA)
To prepare nuclear extracts for EMSA, cells were pelleted and
resuspended inw10 volumes of cell lysis buffer (10 mM Hepes pH 8,
10 mM NaCl, 5 mM MgCl2, 0.5 mM DTT) with added protease in-
hibitors [chymostatin, leupeptin, antipain, and pepstatin A (all from
SigmaeAldrich) at a ﬁnal concentration of 25 mg/ml each] and phos-
phatase inhibitors [activated Na-ortho-vanadate (SigmaeAldrich) at
2 mmol/l ﬁnal concentration and NaF (SigmaeAldrich) at 25 mmol/l
ﬁnal concentration]. After incubating on ice for 30 min, nuclei were
pelleted and 1 volume of nuclei lysis buffer was added (10 mM Hepes
pH 8, 300 mM KCl, 5 mM MgCl2, 0.5 mM DTT, 20% glycerol and
protease and phosphatase inhibitors). Nuclear extracts were incubated
for 30 min on a rotating wheel at 4 C and then centrifuged to remove
insoluble pellet. For EMSA reactions, w2.5 mg of nuclear lysate orMOLECULAR METABOLISM 28 (2019) 135e143  2019 The Authors. Published by Elsevier GmbH. This is an open
www.molecularmetabolism.com10 ng of rHSP70 was used to analyze binding to biotinylated DNA
duplexes harboring the 147-þ78 region of LXRalpha promoter.
EMSA binding reactions, electrophoresis and blotting were performed
by using Gelshift Chemiluminescent EMSA Kit (Active Motif) according
to manufacturer’s instructions.
2.12. Knockdown experiments in THP-1 macrophages
THP-1 cells (from ATCC) were cultivated in RPMI-1640 medium con-
taining 10% FBS, 1% penicillin/streptomycin/L-glutamine and 25 mM
HEPES. Differentiation and nucleofection were performed as previously
described [21]. Before electroporation THP-1 monocytes were pre-
differentiated in growth medium supplemented with 1% sodium py-
ruvate, 1% nonessential amino acids, 10 ng/ml PMA, and 50 mM b-
mercaptoethanol for 48 h. 2.5 10E6 cells were transfected with 1 mg
of GL2-control siRNA, 1 mg of HSP70 siRNA (SigmaAldrich, Cat.
NM005345) or 1 mg of LXRa siRNA (Thermo Fisher, Cat. AM51331)
using a nucleofector kit from Lonza (Cat. VPA-1007). After transfection,
differentiation was continued for 24 h with 2.5 ng/ml PMA. Differen-
tiated cells were loaded with 50 mg/ml acLDL for 2 days. Non-
transfected cells were differentiated continuously for 3 days before
acLDL loading. After loading, cholesterol efﬂux was performed in
medium containing 10% FBS. Treatment with 300 nM rHSP70 or 5 mM
TO901317 for 16 h before efﬂux and during 12 h efﬂux. All samples
were collected at the same point for analysis.
2.13. Fluorescence labeling of cells
Alexa 568-labeled rHSP70 was administered to the cells similarly as
unlabeled rHSP70. Late endosomal/lysosomal compartments were
labeled with Alexa 647 dextran (1:200) (dextran size 1000) (Thermo
Fischer) overnight. Lipid droplets were labeled with HCS Lipid TOX
Green Neutral Lipid Stain (1:1300) (Thermo Fischer) for 30 min prior to
imaging. BODIPY-cholesterol/methyl-b-cyclodextrin complex was
prepared as in [22]. Primary macrophage foam cells maintained in 4-
well Ibidi slides were labeled with 1:1000 BODIPY-cholesterol/methyl-
b-cyclodextrin complex for 5 min at 37 C after 3 days of acLDL
loading. The cells were washed twice with PBS and incubated in
serum-free RPMI for 6 h to equilibrate the label. Sterol efﬂux was
performed in 6% HDL-enriched serum prepared as in [23] for 16 h.
rHSP70 was present during the last 16 h of acLDL loading, the 6h
equilibration and the efﬂux.
2.14. Imaging and image analysis
For monitoring rHSP70 localization, cells were visualized with a
Leica TCS CARS SP8 confocal microscope (Leica, Germany) using
a 63 HC PL APO CS2 glycerol objective. Sequential scans were
taken to avoid cross-talk between channels. To visualize BODIPY-
cholesterol labeling, a fully motorized Nikon Eclipse Ti-E inverted
ﬂuorescent microscope with perfect focus system was used
(Nikon, Japan). Cells were imaged in a live cell chamber at 37 C,
5% CO2. Images were taken every 20 min using a 20 air
objective and Andor iXon 897 illuminated EMCCD camera and
analyzed by ImageJ conﬁgured with a macro plug-in for image
segmentation. The average cellular BODIPY intensity was calcu-
lated based on image segmentation, efﬂux rate is an inverse slope
of diminishing intensity plotted against time. Zebraﬁsh larvae were
stained with LD540 [24] to visualize neutral lipids. On day 15,
larvae were collected and ﬁxed in 4% PFA overnight at 4 C.
LD540 (1:10000) was applied to ﬁsh overnight at 4 C. Samples
were washed, mounted in 85% glycerol and visualized using Leica
TCS CARS SP8 confocal microscope using a 25 water objective.access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 137
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Graphs were generated using Microsoft Excel or GraphPad Prism 6.0.
Data are expressed as mean  SEM. P values were calculated using
two-tailed Student’s t-test and statistical signiﬁcance of the results
exhibited as ***: p < 0.001; **: p < 0.01; *: p < 0.05.
3. RESULTS AND DISCUSSION
3.1. Recombinant HSP70 stimulates cholesterol removal from
primary human macrophage foam cells
Peripheral blood monocytes from human blood donors were differ-
entiated into macrophages during 7 days and incubated with modiﬁed
low-density lipoproteins (acetylated LDL, acLDL) for 3 days (Figure 1A).
This mimics atherosclerotic foam cell formation and results in a
marked increase in the cellular cholesterol content. Free (i.e. unes-
teriﬁed) cholesterol and especially cholesteryl esters, the storage form
of cholesterol in lipid droplets, were markedly increased (Figure 1B).
Cholesterol removal was induced by referring the cells to 10% serum
containing medium. After 12 h of efﬂux, both free and esteriﬁed
cholesterol levels were signiﬁcantly reduced (Figure 1A,B).
To analyze if recombinant HSP70 (rHSP70) can modulate cholesterol
removal, the cells were treated with 300 nM rHSP70 for the last 16 h of
acLDL loading and during efﬂux (Figure 1A). This resulted in aw2-3-
fold increase in cellular HSP70 content (Figure 1C). rHSP70 can be
taken up via scavenger receptors and enter the lysosomes of recipient
cells [12,13,25,26]. In agreement, Alexa Fluor 568-rHSP70 promi-
nently labeled macrophage lysosomes (Figure 1D). Remarkably,
rHSP70 enhanced cholesterol removal from macrophage foam cells, as
evidenced by the decreased cholesteryl ester content compared to
cells incubated in its absence (Figure 1B). A 10-fold higher rHSP70
concentration showed a similar cholesterol reducing efﬁciency (Figure
S1D); therefore, we employed 300 nM rHSP70 in further experiments.
To directly measure cholesterol efﬂux, cells were incubated with [3H]-
cholesterol-labeled acLDL and the partitioning of the radiolabel be-
tween cells and efﬂux medium was analyzed. This showed that
rHSP70 stimulated [3H]-cholesterol efﬂux to both complete serum and
HDL-enriched serum acceptors (Figure 1E). To assess cholesterol
efﬂux rate, foam cells were labeled with BODIPY-cholesterol, a ﬂuo-
rescent sterol analog [27,28], and the removal of the ﬂuorescent sterol
from cells was followed over time by imaging. This showed that
rHSP70 treatment was accompanied by a faster rate of sterol efﬂux
(Figure 1F).
3.2. rHSP70 administration to foam cells results in broad
transcriptional re-programming
Considering the lysosomal targeting of rHSP70 in macrophages, we
investigated if the effect of rHSP70 on cholesterol efﬂux in foam cells
was mediated via its BMP binding. We found that a mutant rHSP70
(W90F-rHSP70) incapable of interacting with BMP [12,29] induced a
similar enhancement of cholesterol efﬂux as the wt rHSP70 (Figure
S1C, D), arguing that BMP binding is not required for this effect.
To further dissect the underlying mechanism, we performed an un-
biased transcriptome analysis of acLDL loaded macrophages under-
going cholesterol efﬂux in the presence or absence of rHSP70 as in
Figure 1A. RNA sequencing of macrophage foam cells from four in-
dividual blood donors revealed that the rHSP70 induced a major
transcriptional reprogramming. These changes were strikingly similar
between individuals, with 3D principal component analysis demon-
strating a clear separation between treatment groups (Figure S2A). Of
the 60 000 transcripts analyzed, w10% were affected by rHSP70
treatment. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway138 MOLECULAR METABOLISM 28 (2019) 135e143  2019 The Authors. Published by Elsevier GmbH. Tenrichment analysis showed multiple pathways to be affected by
rHSP70 administration, with 16% of the altered transcripts associated
with metabolism (Figure 2A). Importantly, heat map analysis revealed a
prominent upregulation of several Liver X Receptor (LXR) target genes
(Figures 2B and S2B). In addition, inﬂammatory and oxidative stress
related transcripts were elevated (Figure S2B, C).
3.3. rHSP70 treatment modulates the expression of LXR and LXR
targets involved in cholesterol metabolism and trafﬁcking
Quantitative RT-PCR (qRT-PCR) analysis of select targets agreed with
the transcript changes observed by RNA sequencing. In particular, the
expression of key gatekeepers of cholesterol removal from macro-
phage foam cells, ABCA1 and ABCG1 [30,31], were markedly
increased upon rHSP70 treatment (Figure 2B,C). Of note, rHSP70 failed
to increase the ABCA1 mRNA in macrophages not loaded with acLDL
(Figure S3A), implying that the effect depends on prior cholesterol
challenging of cells. W90F-rHSP70 efﬁciently upregulated ABCA1 in
loaded cells (Figure S3B), indicating that HSP70 BMP binding is not
required.
The increased ABCA1 mRNA correlated with an increased ABCA1
protein content (Figure 2D), and the combined effect of rHSP70 and
acLDL loading on ABCA1 transcript and protein levels was more
substantial than that induced by acLDL loading alone (Figure 2C,D).
The ABCA1 elevating effect of rHSP70 was highly consistent: alto-
gether, 46 of the 49 blood donors studied (94%) responded to rHSP70
treatment by upregulation of their foam cell ABCA1 mRNA, and an
elevated ABCA1 content was invariably accompanied by enhanced
cholesterol removal from cells. These observations underscore a
robust cholesterol reducing potential of rHSP70 on a heterogeneous
human genetic background.
The mRNA for the cholesterol-binding protein GRAMD1A was also
highly elevated in the presence of rHSP70 (Figure 2B,C) and this was
paralleled by strikingly increased GRAMD1A protein levels (Figure 2D).
The GRAMD/LAM/Aster proteins regulate nonvesicular cholesterol
transport from the plasma membrane to the ER in mammalian cells
[32]. Furthermore, a trend for increased NPC1 protein content in
rHSP70 treated cells was observed (Figure 2D). This, together with the
ABCA1, ABCG1, and GRAMD1A increase speaks for increased cellular
cholesterol mobilizing capacity upon rHSP70 treatment. On the other
hand, some transcripts, such as that encoding fatty acid binding
protein 4 (FABP4), were downregulated by rHSP70 treatment
(Figure 2BeD). This agrees with the idea that rHSP70 induces an anti-
atherogenic transcriptional program, as FABP4 deﬁciency has been
linked to reduced macrophage accumulation in atherosclerotic plaques
and diminished lesion size [33].
3.4. rHSP70 binds to the LXRalpha promoter and induces its
expression
Notably, rHSP70 treatment also increased the LXRalpha transcript
encoded by the NR1H3 gene (Figure 2B,C), suggesting that the in-
crease in key LXR target mRNAs is generated by their enhanced
synthesis via this transcription factor. Indeed, treatment of foam cells
with the transcription inhibitor actinomycin D for the last 4 h of
cholesterol efﬂux abrogated the rHSP70 induced increase in ABCA1
mRNA (Figure 2E). This implies that HSP70 does not act via mRNA
stabilization as in some other settings [34,35] but by activating
LXRalpha and thereby increasing transcription of its target genes.
Accordingly, LXRalpha silencing inhibited the rHSP70 induced ABCA1
upregulation in macrophages (Figure S4). Importantly, LXRalpha ap-
pears as a limiting factor for cholesterol efﬂux in primary human
macrophages [36].his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1: rHSP70 stimulates cholesterol removal from primary human macrophage foam cells. (A) Differentiated human macrophages were loaded with 50 mg/ml acLDL for
3 days and cholesterol efﬂux performed in medium containing 10% FBS /þ 300 nM rHSP70 for 12 h. Red arrows indicate time points of sample collection. (B) Free and esteriﬁed
cholesterol was analyzed at indicated times and normalized to protein amount. n ¼ 8 donors from 8 experiments with three technical replicates. Change in cholesteryl esters in
efﬂux /þ rHSP70 is shown for each individual. (C) Cells were harvested and proteins separated by SDS-PAGE and analyzed by western blotting using anti-HSP70 antibodies, Pro-
act staining as loading control. Band intensities were normalized to NL, n ¼ 6 donors. (D) Fluorescence microscopy of foam cells incubated with Alexa 568-labeled rHSP70. Lipid
droplets were labeled with Lipid Tox and late endosomal compartments with Alexa-647 dextran. Inset shows late endosomes in the cell periphery, dashed line indicates cell border.
Scale bar, 10 mm. (E) [3H]cholesterol efﬂux to complete or HDL-enriched serum from foam cells incubated in the presence or absence of rHSP70 as in 1A. Data from cells of 3
donors with 3 technical replicates. (F) BODIPY-cholesterol labeled foam cells were imaged for 16 h /þ rHSP70. Sterol efﬂux rate as intensity/cell area/h. Data normalized to
control, mean  SEM. t-test ***: p < 0.001; *: p < 0.05.
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Figure 2: rHSP70 induces broad transcriptional re-programming, interacts with LXRalpha promoter and affects the expression of key macrophage proteins involved in
lipid transport. (A) Foam cells from 4 blood donors were incubated /þ rHSP70 during cholesterol efﬂux and subjected to RNA sequencing. Chart shows relative distribution of
genes modulated by rHSP70 using the main KEGG classiﬁcation of genes, number of affected genes in each class is indicated. (B) Heatmap illustrates modulation of lipid
metabolism related targets by rHSP70, log2 values of RNA levels in the 4 individuals /þ rHSP70. See Figure S2B for Ensemble IDs of transcripts. (C) Validation of select lipid
metabolism related transcripts using qRT-PCR, n ¼ 6 donors with triplicate measurements. (D) Western blotting using the indicated antibodies, Pro-act staining as loading control,
band intensities normalized to NL. n ¼ 3e7 donors. (E) ABCA1 transcript levels during cholesterol efﬂux /þ rHSP70 as in Figure 1A, with last 4 h of efﬂux /þ actinomycin D
(5 mg/ml), n ¼ 3 donors. Data normalized to control at ﬁrst time point, mean  SEM. (F) Confocal section of a primary human foam cell incubated with Alexa 568-labeled rHSP70
for 3 h and stained with DAPI, nuclear labeling indicated by arrowheads. (G) Chromatin immunoprecipitation in primary human macrophage foam cells using anti-HSP70 antibody
or irrelevant anti-HA antibody and ampliﬁed by qRT-PCR for LXRalpha proximal promoter region. Fold enrichment over anti-HA control is shown for each of the 13 donors analyzed.
Data are mean  SEM. t-test ***: p < 0.001; **: p < 0.01; *: p < 0.05.
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Figure 3: Pharmacological induction of endogenous HSP70 activates LXR and lowers cholesterol in high cholesterol diet fed zebraﬁsh. (A) Zebraﬁsh larvae fed with Normal
Diet (ND) or High Cholesterol Diet (HCD) for 10 days starting from 5 dpf/þ HSP70 inducers (1 mM 17-DMAG, 50 mM BGP-15 or 50 mM BM). On day 15, ﬁsh were harvested for qRT-PCR
or cholesterol determination. (B) Lipid accumulation in liver (dashed line) of HCD fed animals visualized by the neutral lipid dye LD540. Scale bar, 50 mm. (C) Representative images of ﬁsh
on day 15. (D) hsp70, lxr, abca1, and abcg1mRNA levels were measured by qRT-PCR, n¼ 14 ﬁsh/condition, two experiments for hsp70 and n¼ 20 ﬁsh/condition, three experiments for
lxr, abca1 and abcg1. (E) Analysis of ﬁsh cholesterol content, each symbol corresponds to a pool of 5 ﬁsh, total n¼ 30e45 ﬁsh/condition from three experiments. (F) Schematic model. In
cholesterol loaded cells, LXR pathway is activated by endogenous sterol ligands, leading to upregulation of LXR targets, such as ABCA1, and stimulation of cholesterol efﬂux. This process
can be boosted by administration of rHSP70 or pharmacological induction of endogenous HSP70, by HSP70 binding to positive regulatory elements in LXRalpha promoter presumably in
complex with other proteins and enhancing LXRalpha transcription. Data are mean  SEM, t-test ***: p < 0.001; **: p < 0.01; *: p < 0.05.When studying the kinetics of ABCA1 and NR1H3 mRNA upregulation,
we found that the transcriptional response occurs rapidly, within 3 h
upon rHSP70 administration to foam cells (Figure S3C, D). Moreover, a
minor fraction of Alexa 568-labeled rHSP70 localized to the nucleus
(Figure 2F). To investigate if rHSP70 can associate with the LXRalpha
promoter in primary human macrophage foam cells, we collected
samples incubated for 3 h with rHSP70 and performed chromatinMOLECULAR METABOLISM 28 (2019) 135e143  2019 The Authors. Published by Elsevier GmbH. This is an open
www.molecularmetabolism.comimmunoprecipitation (ChIP) with anti-HSP70 (or anti-HA control) anti-
bodies followed by qRT-PCR of the LXRalpha promoter [37].
This revealed speciﬁc binding of HSP70 to the proximal region of
the LXRalpha promoter known to contain positive regulatory
elements (Figure 2G; no speciﬁc binding to NR1H3 distal region was
found, Figure S3E). This ﬁnding was corroborated by EMSA demon-
strating that while rHSP70 did not directly bind to the proximal region ofaccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 141
Brief Communicationthe LXRalpha promoter, silencing of endogenous HSP70 abolished the
mobility shift induced by binding of nuclear proteins to this area (Figure
S3F). The involvement of endogenous HSP70 was also suggested by
experiments showing that HSP70 silencing in macrophages abrogates
the rHSP70 induced upregulation of the NR1H3 mRNA (Figure S4).
Together, these ﬁndings provide the ﬁrst indication that HSP70 can
interact with the macrophage LXRalpha promoter, potentially in co-
operation with other NR1H3 regulators, thereby enhancing its tran-
scription. These data add to the growing list of HSP70 nuclear functions
that extend beyond its classical cytoplasmic chaperone activities [38].
3.5. Upregulation of endogenous HSP70 activates the LXR pathway
and enhances cholesterol removal in hypercholesterolemic zebraﬁsh
Zebraﬁsh become hypercholesterolemic upon high cholesterol diet
(HCD), representing an in vivo model for atherosclerosis and liver
steatosis studies [39,40]. To induce cholesterol accumulation in
zebraﬁsh larvae, we fed them for 10 days with HCD starting from
5 dpf (Figure 3A). This results in pronounced lipid accumulation
in tissues (Figure 3B), increased cholesterol storage as cholesteryl
esters at the whole animal level (Figure 3E) and upregulation
of hsp70 mRNA (Figure S5) as compared to larvae fed with a
standard diet.
As further boosting zebraﬁsh HSP70 levels by administering rHSP70 to
the swimming water was unsuccessful, we analyzed if pharmaco-
logical increase of endogenous HSP70 levels can enhance cholesterol
removal. HSP90 inhibitors, such as 17-dimethylaminoethylamino-17-
demethoxy-geldanamycin (17-DMAG) disrupt HSP90-HSF complexes,
allowing HSF activation and nuclear translocation to transactivate HSP
genes [41]. Indeed, we found that 17-DMAG not only increased
endogenous HSP70 in primary human foam cells but also ABCA1
protein levels (Figure S6). On the other hand, hydroxylamine de-
rivatives such as O-(2-hydroxy-3-piperidinepropyl)-pyridine-carbonic
acid-amidoxime dihydrochloride (BGP-15) and N-[2-hydroxy-3(1-
piperidinyl) propoxy]-3 pyridine carboximidoyl-chloride maleate
(Bimoclomol, BM) act as HSP co-inducers by amplifying the expression
of HSPs induced by mild stress [42].
We administered 17-DMAG, BGP-15 or BM into the zebraﬁsh swim-
ming water, starting concurrently with the onset of HCD feeding (Figure
3A). The compounds did not exhibit toxic effects in the ﬁsh (Figure 3C)
and were capable of increasing their endogenous hsp70 mRNA levels
(Figure 3D). Biochemical analysis of whole ﬁsh treated with HCD for 10
days revealed a markedly lower cholesterol content, in particular as
cholesteryl esters, in the drug-treated animals (Figure 3E). This was
observed with all three compounds, implying that induction of
endogenous Hsp70 by several mechanisms exerted a cholesterol-
lowering effect in vivo. This is likely mechanistically coupled to LXR
activation analogously to human foam cell macrophages, as evidenced
by the elevated lxr, abca1 and abcg1 transcript levels in the HCD-fed
ﬁsh upon HSP70 induction (Figure 3D). Indeed, our ﬁndings suggest
that the earlier reported atheroprotective effects of 17-DMAG in mice
[7,8] may also involve LXR activation.
4. CONCLUSION
Together, this study provides evidence that HSP70 exerts athero-
protective effects in vitro and in vivo and that this can be mech-
anistically explained by HSP70 mediated stimulation of the liver X
receptor (LXR), the master regulator of whole-body cholesterol
removal. HSP70 was found to bind to the LXRalpha promoter,
enhance its transcription and boost the expression of key LXR
targets under cholesterol loaded conditions (Figure 3F). These142 MOLECULAR METABOLISM 28 (2019) 135e143  2019 The Authors. Published by Elsevier GmbH. Tﬁndings reveal a function for HSP70 in regulating cholesterol
metabolism, uncover a cross-talk between HSP and LXR tran-
scriptional regulation, and suggest that HSP70 induction may
provide a treatment paradigm in pathological conditions related to
cholesterol accumulation.
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